Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Base Catalyzed Hydrogen Deuterium Exchange. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113461624B reveals a breakthrough method for selective C4/C5 mono-deuteration of 1,2,3-triazoles, offering high purity and cost-effective manufacturing for pharmaceutical intermediates.